tm-30339
Peptideexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2008 (NCT00746824)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
NPY4R agonist
Pancreatic polypeptide analogue. Phase 2 study terminated.
- Pancreatic prohormoneSupplementation
PPY supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545106 ↗
Also known as
- tm30339
- tm30339
- tm30339
- tm-30339
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00746824 | Phase 2 | Aug 1, 2008 | 7TM Pharma A/S |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| 7TM Pharma A/S | For profit | 1 | 1 | 1 | 2008 |
1 organizations
Page 1 / 1